Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Automatic Immunohistochemical Staining Instrument Market Forecast: What Value Will The Market Reach By 2030?
The automatic immunohistochemical staining instrument market has experienced robust expansion in recent years. It is projected to increase from $1.3 billion in 2025 to $1.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth in this market can be attributed to factors such as rising volumes of cancer diagnostic testing, the expansion of pathology laboratory infrastructure, greater reliance on immunohistochemistry in diagnosing diseases, the increasing availability of automated laboratory instruments, and a growing demand for reproducible diagnostic results.
The automatic immunohistochemical staining instrument market is projected to experience substantial expansion in the coming years, anticipated to reach $1.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth is driven by factors such as the increasing embrace of precision oncology diagnostics, rising investments in digital pathology solutions, a growing need for laboratory automation, the broadened development of companion diagnostics, and an intensified emphasis on personalized medicine strategies. Key trends during this forecast period encompass the heightened adoption of fully automated IHC staining systems, an increasing need for high-throughput diagnostic processes, the expanding integration of digital pathology compatibility, the spread of standardized and reproducible staining protocols, and a stronger emphasis on laboratory workflow efficiency.
Get A Free Sample Report With In-Depth Market Insights:
Automatic Immunohistochemical Staining Instrument Market Growth Backed By Core Demand Fundamentals
The increasing prevalence of chronic diseases is projected to drive the expansion of the automatic immunohistochemical staining instrument market. Chronic diseases are defined as enduring medical conditions that typically advance slowly and require ongoing management, including conditions such as diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rising occurrence of these diseases is linked to lifestyle changes, inadequate diet, and a lack of physical activity, which contribute to long-term health complications. Automatic immunohistochemical staining instruments enhance diagnostic capabilities by performing precise and efficient tissue analysis, making them vital for detecting chronic diseases. They minimize manual effort through rapid, automated staining processes, thereby improving diagnostic accuracy and enabling earlier identification of diseases. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is a significant factor boosting the automatic immunohistochemical staining instrument market.
Automatic Immunohistochemical Staining Instrument Market Segment Breakdown: Which Categories Lead On Revenue?
The automatic immunohistochemical staining instrument market covered in this report is segmented –
1) By Product Type: Fully Automated Stainers, Semi-Automated Stainers, Manual Stainers
2) By Technology: Slide Staining, Tissue Staining, Fluorescent Staining
3) By Consumables: Antibodies, Staining Kits, Slides, Coverslips
4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases
5) By End-User: Hospitals, Diagnostic Laboratories, Academic Institutes, Research Laboratories
Subsegments:
1) By Fully Automated Stainers: Compact Automated Stainers, High-Throughput Stainers, Benchtop Automated Stainers
2) By Semi-Automated Stainers: Programmable Stainers, Timer-Based Stainers, Hybrid Stainers
3) By Manual Stainers: Dip-Type Manual Stainers, Rotary Manual Stainers, Handheld Staining Kits
Automatic Immunohistochemical Staining Instrument Market Growth Trends Reshaping The Competitive Landscape
Major companies operating in the automatic immunohistochemical staining instrument market are concentrating on creating innovative solutions, such as antibody alternative reagents, to enhance the accuracy, efficiency, and versatility of tissue analysis while simultaneously reducing costs and improving reproducibility. An antibody alternative reagent describes a non-antibody molecule like an aptamer, affirmer, or antibody mimetic that can specifically attach to target antigens and is utilized in place of traditional antibodies for research, diagnostic, or therapeutic purposes. For example, in March 2023, Aptamer Group plc, a UK-based biotechnology company, unveiled Optimer-Fc, a novel reagent solution intended for automated immunohistochemistry (IHC) workflows. Optimer-Fc offers a groundbreaking antibody alternative for immunohistochemistry, expanding target detection capabilities and improving assay selectivity. It integrates smoothly into automated immunohistochemistry (IHC) workflows to accurately identify both established and new biomarkers.
Automatic Immunohistochemical Staining Instrument Market Leading Players And Competitive Positioning
Major companies operating in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Agilent Technologies, Leica Biosystems, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co. Ltd., BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co. Ltd., Ventana Medical Systems, Dako (Agilent Pathology), Nichirei Biosciences Inc., Abcam plc, Bio-Rad Laboratories, Milestone Medical, Medite GmbH
View The Full Automatic Immunohistochemical Staining Instrument Market Report:
Automatic Immunohistochemical Staining Instrument Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the automatic immunohistochemical staining instrument market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic immunohistochemical staining instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
